Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

2.

Caring for relatives with agitation at home: a qualitative study of positive coping strategies.

Hoe J, Jesnick L, Turner R, Leavey G, Livingston G.

BJPsych Open. 2017 Feb 9;3(1):34-40. doi: 10.1192/bjpo.bp.116.004069. eCollection 2017 Jan.

3.

Dysfunction of ventrolateral striatal dopamine receptor type 2-expressing medium spiny neurons impairs instrumental motivation.

Tsutsui-Kimura I, Takiue H, Yoshida K, Xu M, Yano R, Ohta H, Nishida H, Bouchekioua Y, Okano H, Uchigashima M, Watanabe M, Takata N, Drew MR, Sano H, Mimura M, Tanaka KF.

Nat Commun. 2017 Feb 1;8:14304. doi: 10.1038/ncomms14304.

4.

The association of antidepressant drug usage with cognitive impairment or dementia, including Alzheimer disease: A systematic review and meta-analysis.

Moraros J, Nwankwo C, Patten SB, Mousseau DD.

Depress Anxiety. 2017 Mar;34(3):217-226. doi: 10.1002/da.22584. Epub 2016 Dec 28.

5.

Genetic architecture of sporadic frontotemporal dementia and overlap with Alzheimer's and Parkinson's diseases.

Ferrari R, Wang Y, Vandrovcova J, Guelfi S, Witeolar A, Karch CM, Schork AJ, Fan CC, Brewer JB; International FTD-Genomics Consortium (IFGC),; International Parkinson's Disease Genomics Consortium (IPDGC),; International Genomics of Alzheimer's Project (IGAP),, Momeni P, Schellenberg GD, Dillon WP, Sugrue LP, Hess CP, Yokoyama JS, Bonham LW, Rabinovici GD, Miller BL, Andreassen OA, Dale AM, Hardy J, Desikan RS.

J Neurol Neurosurg Psychiatry. 2017 Feb;88(2):152-164. doi: 10.1136/jnnp-2016-314411. Epub 2016 Nov 29.

6.

Fus1 KO Mouse As a Model of Oxidative Stress-Mediated Sporadic Alzheimer's Disease: Circadian Disruption and Long-Term Spatial and Olfactory Memory Impairments.

Coronas-Samano G, Baker KL, Tan WJ, Ivanova AV, Verhagen JV.

Front Aging Neurosci. 2016 Nov 15;8:268. eCollection 2016.

7.

Alzheimer and vascular dementia in the elderly patients.

Seetlani NK, Kumar N, Imran K, Ali A, Shams N, Sheikh T.

Pak J Med Sci. 2016 Sep-Oct;32(5):1286-1290.

8.

Implementation of subjective cognitive decline criteria in research studies.

Molinuevo JL, Rabin LA, Amariglio R, Buckley R, Dubois B, Ellis KA, Ewers M, Hampel H, Klöppel S, Rami L, Reisberg B, Saykin AJ, Sikkes S, Smart CM, Snitz BE, Sperling R, van der Flier WM, Wagner M, Jessen F; Subjective Cognitive Decline Initiative (SCD-I) Working Group.

Alzheimers Dement. 2017 Mar;13(3):296-311. doi: 10.1016/j.jalz.2016.09.012. Epub 2016 Nov 5.

PMID:
27825022
9.

COMPASS: A computational model to predict changes in MMSE scores 24-months after initial assessment of Alzheimer's disease.

Zhu F, Panwar B, Dodge HH, Li H, Hampstead BM, Albin RL, Paulson HL, Guan Y.

Sci Rep. 2016 Oct 5;6:34567. doi: 10.1038/srep34567.

10.

Neuropsychiatric Disturbances in Alzheimer's Disease: What Have We Learned from Neuropathological Studies?

Van Dam D, Vermeiren Y, Dekker AD, Naudé PJ, Deyn PP.

Curr Alzheimer Res. 2016;13(10):1145-64. Review.

11.

Comorbidity Factors and Brain Mechanisms Linking Chronic Stress and Systemic Illness.

Duric V, Clayton S, Leong ML, Yuan LL.

Neural Plast. 2016;2016:5460732. doi: 10.1155/2016/5460732. Epub 2016 Feb 8. Review.

12.

Locus Coeruleus, norepinephrine and Aβ peptides in Alzheimer's disease.

Ross JA, McGonigle P, Van Bockstaele EJ.

Neurobiol Stress. 2015;2:73-84.

13.

Apathy in Frontotemporal Degeneration: Neuroanatomical Evidence of Impaired Goal-directed Behavior.

Massimo L, Powers JP, Evans LK, McMillan CT, Rascovsky K, Eslinger P, Ersek M, Irwin DJ, Grossman M.

Front Hum Neurosci. 2015 Nov 10;9:611. doi: 10.3389/fnhum.2015.00611. eCollection 2015.

14.

Cognitive behavioural treatment for mild Alzheimer's patients and their caregivers (CBTAC): study protocol for a randomized controlled trial.

Forstmeier S, Maercker A, Savaskan E, Roth T.

Trials. 2015 Nov 17;16:526. doi: 10.1186/s13063-015-1043-0.

15.

The Apathy Evaluation Scale: A Comparison of Subject, Informant, and Clinician Report in Cognitively Normal Elderly and Mild Cognitive Impairment.

Guercio BJ, Donovan NJ, Munro CE, Aghjayan SL, Wigman SE, Locascio JJ, Amariglio RE, Rentz DM, Johnson KA, Sperling RA, Marshall GA.

J Alzheimers Dis. 2015;47(2):421-32. doi: 10.3233/JAD-150146.

16.

Depressive symptoms in neurodegenerative diseases.

Baquero M, Martín N.

World J Clin Cases. 2015 Aug 16;3(8):682-93. doi: 10.12998/wjcc.v3.i8.682. Review.

17.

Usability of a Wearable Camera System for Dementia Family Caregivers.

Matthews JT, Lingler JH, Campbell GB, Hunsaker AE, Hu L, Pires BR, Hebert M, Schulz R.

J Healthc Eng. 2015;6(2):213-38.

18.

Use of Benzodiazepines in Alzheimer's Disease: A Systematic Review of Literature.

Defrancesco M, Marksteiner J, Fleischhacker WW, Blasko I.

Int J Neuropsychopharmacol. 2015 May 19;18(10):pyv055. doi: 10.1093/ijnp/pyv055. Review.

19.

Neuropsychiatric Symptoms and Functional Connectivity in Mild Cognitive Impairment.

Munro CE, Donovan NJ, Guercio BJ, Wigman SE, Schultz AP, Amariglio RE, Rentz DM, Johnson KA, Sperling RA, Marshall GA.

J Alzheimers Dis. 2015;46(3):727-35. doi: 10.3233/JAD-150017.

20.

Apathy is associated with lower inferior temporal cortical thickness in mild cognitive impairment and normal elderly individuals.

Guercio BJ, Donovan NJ, Ward A, Schultz A, Lorius N, Amariglio RE, Rentz DM, Johnson KA, Sperling RA, Marshall GA.

J Neuropsychiatry Clin Neurosci. 2015 Winter;27(1):e22-7. doi: 10.1176/appi.neuropsych.13060141. Epub 2014 Nov 10.

Supplemental Content

Support Center